Salud

It’s been a year of anticipation for Lykos Therapeutics, as they await a landmark decision from the Food and Drug Administration (FDA). The drugmaker had filed an application to approve MDMA as a treatment for PTSD, expecting a positive outcome that would catapult them to new heights. However, on August 9, the FDA responded with a rebuttal, culminating growing concerns about the quality of Lykos’ clinical trials. Following the decision, the journal Psychopharmacology retracted three studies related to MDMA research, citing unethical practices and making serious allegations, including sexual misconduct by an unlicensed therapist at one of the study sites.…

Researchers conducted a unique study involving 31 individuals, mostly males from the United States and the United Kingdom, who shared their experiences with both near-death states and psychedelics. The results of this study were recently published, shedding light on the complex relationship between these two profound states of consciousness. Study participants provided detailed descriptions of their encounters during near-death experiences and while on psychedelics. Although each experience was unique, notable similarities were also reported, suggesting an intriguing overlap between the two. One participant described experiencing an overwhelming sense of peace and love during his near-death experience, a feeling echoed by…

Recent congressional actions have highlighted concerns about certain health insurance practices that could increase financial burdens for both patients and employers. At the center of these investigations is MultiPlan, a well-known data analytics firm known for its role in helping insurers determine medical claim payout amounts. On Tuesday, Reps. Bobby Scott (D-VA) and Mark DeSaulnier (D-CA), who hold leadership roles on a key House committee that deals with employer-sponsored insurance, sent a detailed request to a senior Labor Department official. They asked for a full explanation of the measures being taken against what they called “disturbing practices” in the health…

Gabapentin, a drug originally developed for epilepsy, has found new life as a multipurpose pain reliever adopted by seniors for ailments ranging from nerve pain to muscle aches. This versatile medication has become a daily staple for many seniors seeking relief from chronic conditions. In Manchester-by-the-Sea, Massachusetts, Mary Peart, 67, a retired nurse, recounts her experience with gabapentin, which she began using a year and a half ago to ease symptoms of fibromyalgia. The drug has significantly improved her mobility, allowing her to do daily activities like climbing stairs, walking her dog, and taking art classes. “It’s transformative,” she notes.…

At the Luxor Museum in Egypt, the statue of Amenhotep, a seated scribe from the 18th Dynasty (ca. 1550 BC - 1292 BC), embodies more than just artistic interpretation; it represents the physical toll of repetitive work endured by ancient scribes. These historical figures, integral to the bureaucratic machinery of ancient Egypt, likely experienced ergonomic problems similar to those faced by modern office workers. Ancient scribes, recognized more for their intellectual contributions than their manual labor, held positions of considerable respect. They were instrumental in administrative duties that included legal documentation and logistical planning, crucial to managing social resources and…